A potential White House request for billions of dollars in monkeypox funding could find itself ensnared in an impasse on Capitol Hill over additional Covid-19 dollars.
Lawmakers have been struggling for most of this year to agree on new funding for Covid-19 pandemic programs that the White House has warned are running low on money. Turning their attention to a new health threat could prove even trickier.
“The fact that Congress hasn’t gotten any stomach to fund Covid—which we know we need that money"—could mean delays in procuring monkeypox funds as public health departments are grappling with two big outbreaks, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.